← back to search

Grant R. Goodman

Scripps MD Anderson Cancer Center ·
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Colorectal Cancer Treatments and Studies, and Chronic Lymphocytic Leukemia Research.
h-index
15
citations
1,063
works
28
NIH funding
primary concept
Medicine
email

Recent publications

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib
Annals of Oncology 2020cited by 59position: middledoi
Health-related quality of life in patients with fully resected BRAFV600 mutation–positive melanoma receiving adjuvant vemurafenib
European Journal of Cancer 2019cited by 9position: middledoi
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
The Lancet Oncology 2018cited by 214position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Piotr Rutkowski · Maria Curie-Skłodowska University2 papers (2019–2020)Brian Simmons · Dartmouth Psychiatric Research Center2 papers (2019–2020)Anna Maria Di Giacomo · University of Siena2 papers (2019–2020)Karl D. Lewis · Regeneron (United States)2 papers (2019–2020)Lev Demidov · Humboldt-Universität zu Berlin2 papers (2019–2020)Alexander Guminski · The University of Sydney2 papers (2019–2020)Igor Bondarenko · Dnipro State Medical University2 papers (2019–2020)Paolo A. Ascierto · Parker Institute for Cancer Immunotherapy2 papers (2019–2020)Andrzej Maćkiewicz · Poznan University of Medical Sciences2 papers (2019–2020)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori2 papers (2019–2020) · 1 papers (2019–2019) · 1 papers (2019–2019)C Herbert · University Hospitals Bristol NHS Foundation Trust1 papers (2020–2020)Chenglin Ye · McMaster University1 papers (2019–2019)Matthew Wongchenko · Genesys (United States)1 papers (2020–2020)Mario Mandalà · Cancer Research UK Manchester Institute1 papers (2020–2020)Gregory Hooper · Roche (United Kingdom)1 papers (2020–2020) · 1 papers (2019–2019)C. Ye · 1 papers (2020–2020)Y. Yan · Ningbo University1 papers (2020–2020)